What is Ultimovacs ASA (ULTI.OL)?

Ultimovacs ASA (ULTI.OL) is a stock in the Healthcare sector, Biotechnology industry. View full analysis on Stocks360.

Ultimovacs ASA (ULTI.OL)

Stock analysis · OSL · Healthcare · Biotechnology

Market Cap

N/A

PE (TTM)

N/A

EPS (TTM)

N/A

Dividend Yield

N/A

Beta

0.79

Day Range

N/A

52-wk Range

N/A

Avg Volume

N/A

Volume

N/A

Ultimovacs ASA (ULTI.OL) is a publicly traded company in the Healthcare sector. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.

Get full analysis → Short-Term Analysis →

Earnings

Most Recent

Feb 17, 2022

EPS $-1.60 vs est. $-1.43

Missed by $0.17

Proprietary Signals

Signal snapshot temporarily unavailable.

About Ultimovacs ASA

Ultimovacs ASA is a pharmaceutical company based in Oslo, Norway, established in 2011. The firm specializes in developing immunotherapies to combat various cancers. Its main product in development is UV1, a peptide vaccine engineered to stimulate a T-cell immune response against telomerase, an antigen found widely across different cancer types.